A2V.F Zhejiang Taimei Medical Technology Co., Ltd.
- Market cap
- EUR 271M
- P/E
- -
- P/B
- 1.84x
- ROE
- -3.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is A2V.F undervalued?
Graham numberThe Graham number of Zhejiang Taimei Medical Technology Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Zhejiang Taimei Medical Technology Co., Ltd. fundamental analysis
No fundamental analysis for Zhejiang Taimei Medical Technology Co., Ltd. yet.
Zhejiang Taimei Medical Technology Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Zhejiang Taimei Medical Technology Co., Ltd.
Zhejiang Taimei Medical Technology Co., Ltd. provides digital solutions for life sciences research, development, and commercialization in Mainland China and internationally. The company offers Wiz.AI, an AI platform for clinical trials; TrialOS pharmaceutical R&D collaboration platform; PharmaOS, a pharmaceutical digital marketing platform; and the enterprise-medical academic interaction platform. It also provides pharmaceutical R&D solutions comprising eCollect, eBalance, e…
Full company profileZhejiang Taimei Medical Technology Co., Ltd. financial statements
Zhejiang Taimei Medical Technology Co., Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 466M | 549M | 573M | 551M | 513M |
| Gross Profit | 164M | 185M | 179M | 225M | 218M |
| Operating Income | -458M | -476M | -390M | -254M | -51.1M |
| EBITDA | - | -364M | -303M | -177M | -29.9M |
| Net Income | -480M | -413M | -347M | -215M | -42.8M |
| EPS | -0.86 | -0.74 | -0.62 | -0.38 | -0.08 |
| Balance Sheet | |||||
| Total Assets | 1.80B | 1.83B | 1.44B | 1.58B | 1.56B |
| Total Liabilities | 394M | 442M | 403M | 349M | 365M |
| Shareholders' Equity | 1.41B | 1.31B | 978M | 1.16B | 1.12B |
| Cash & Short-term Investments | 679M | 667M | 518M | 319M | 625M |
| Cash Flow | |||||
| Operating Cash Flow | -218M | -329M | -351M | -202M | -39.4M |
| Capital Expenditure | 32.4M | 28.2M | 9.48M | 5.68M | 3.77M |
| Free Cash Flow | -250M | -357M | -361M | -207M | -43.1M |
| Ratios | |||||
| ROE | -34.0% | -31.5% | -35.4% | -18.5% | -3.8% |
| ROA | -26.6% | -22.6% | -24.0% | -13.6% | -2.8% |
| Net Profit Margin | -102.9% | -75.2% | -60.5% | -38.9% | -8.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Zhejiang Taimei Medical Technology Co., Ltd. dividends
Zhejiang Taimei Medical Technology Co., Ltd. has not paid dividends in the last 5 fiscal years.
Who owns Zhejiang Taimei Medical Technology Co., Ltd.
- Insiders 17.96%
- Institutions 41.38%
- Public & others 40.66%
- Shares outstanding 190M
- Free float 113M
Zhejiang Taimei Medical Technology Co., Ltd. company profile
- Company name
- Zhejiang Taimei Medical Technology Co., Ltd.
- Ticker
- A2V.F
- ISIN
- CNE100006M66
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Information Services
- Employees
- 687
- Fiscal year end
- December
- Address
- Building 9, Jiaxing, China
- Phone
- 86 573 8268 2386
- Website
- taimei.com
About Zhejiang Taimei Medical Technology Co., Ltd.
Zhejiang Taimei Medical Technology Co., Ltd. provides digital solutions for life sciences research, development, and commercialization in Mainland China and internationally. The company offers Wiz.AI, an AI platform for clinical trials; TrialOS pharmaceutical R&D collaboration platform; PharmaOS, a pharmaceutical digital marketing platform; and the enterprise-medical academic interaction platform. It also provides pharmaceutical R&D solutions comprising eCollect, eBalance, eCooperate, eArchives, eImage medical imaging evaluation system, eSMS site management system, Paylite financial management system, and eCollege training management system; TrialPartner digital SMO services, IRC independent review center solutions, and eSAE clinical trial safety information management system; eSitePro clinical trial management platform, eTrialPro research ward management system, GCP-X intelligent clinical trial platform, IIT-EDC research data collection system, eScreening subject information management system, eMonitoring intelligent remote monitoring system, and IDS investigational drug services; and IDCT intelligent decentralized clinical trial. In addition, the company offers eSafety pharmacovigilance compliance management system; eSAE clinical trial safety information management system; ONECEM omni-channel marketing platform, such as ONECEM-SFE sales operation system, ONECEM-SCRM intelligent marketing system, and ONECEM-event+engagement system; and ONEInsight marketing data platform, including boundless corporate medical interaction platform. Further, it provides research and development support; technical, clinical operation, data management, statistical analysis, and management services; independent image evaluation services; and pharmaceutical marketing and institution digitalization solutions. The company was formerly known as Jiaxing Taimei Medical Technology Co., Ltd. Zhejiang Taimei Medical Technology Co., Ltd.was founded in 2013 and is headquartered in Jiaxing, China.
Zhejiang Taimei Medical Technology Co., Ltd. management
9- Mr. Zhao LuExecutive Chairman · born 1979
- Mr. Yiming LuCTO & Director · born 1982
- Ms. Xiaomei NiExecutive Director, Legal Director & Board secretary · born 1972
- Mr. Yufei HuangExecutive Director & Head of the operations assurance division · born 1980
- Mr. Hongwei ZhangHead of Digital Marketing Division & Executive Director · born 1981
- Mr. Dong MaChief Product Officer & Director · born 1984
- Ms. Yunyun WanGM & Executive Director · born 1985
- Mr. Wei WangChief Financial Officer · born 1989
- Mr. Ping Yeung PoonJoint Secretary